Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer

MLA

Ades, S., et al. “Tumor Oncogene (KRAS) Status and Risk of Venous Thrombosis in Patients with Metastatic Colorectal Cancer.” Journal of Thrombosis and Haemostasis, vol. 13, no. 6, June 2015, pp. 998–1003. EBSCOhost, https://doi.org/10.1111/jth.12910.

APA

Ades, S., Kumar, S., Alam, M., Goodwin, A., Weckstein, D., Dugan, M., Ashikaga, T., Evans, M., Verschraegen, C., & Holmes, C. E. (2015). Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer. Journal of Thrombosis and Haemostasis, 13(6), 998–1003. https://doi.org/10.1111/jth.12910

Chicago

Ades, S., S. Kumar, M. Alam, A. Goodwin, D. Weckstein, M. Dugan, T. Ashikaga, M. Evans, C. Verschraegen, and C.E. Holmes. 2015. “Tumor Oncogene (KRAS) Status and Risk of Venous Thrombosis in Patients with Metastatic Colorectal Cancer.” Journal of Thrombosis and Haemostasis 13 (6): 998–1003. doi:10.1111/jth.12910.